Founded in 2014, TigerYeah Capital team has in-depth experiences in investment management and professional healthcare background. TigerYeah is dedicated to build itself as a famous brand in healthcare investment field and become the top tier investment firm. Relying on their superior professional management team, TigerYeah will enable both clients and invested portfolio enterprises to gain the success.TigerYeah focuses on early and growing equity investment in healthcare, especially in the field of the Medical Device, Health Food, CRO and Health Services. By leveraging Tigermed solid platform and TigerYeah abundant industrial knowhow and resources, TigerYeah provides comprehensive post-investment services for entrepreneurs to accelerate the products' launch into market,speed up business development process, strengthen and upgrade the integration of the relevant industrial resources. TigerYeah is willing to contribute greater value as well as grow together with the enterprises.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 7, 2022
Epigenic Therapeutics
|
Seed | $20M | Biotechnology | — |
Mar 3, 2022
Tingsheng Technology
|
Series A | ¥100M | Health Care | — |
Jan 11, 2022
Enze Kangtai
|
Series A | — | Biopharma | — |
Dec 27, 2021
Hesguard
|
Seed | ¥100M | Eyewear | — |
May 12, 2021
Hangzhou DAC Biotech Co., Ltd
|
Series C | ¥1B | Biotechnology | — |